Title: Clinical Pearls in Osteoporosis
This presentation will address the following topic areas:
1. How do we assess fracture risk? What do we mean by imminent fracture risk?
2. What are the benefits and risks of osteoporosis treatment?
3. Drug holidays: When do we stop therapy, if ever?
4. What do RCT’s of bisphosphonate versus denosumab tell us?
5. When do you measure BMD? Does change in BMD reflect fracture risk reduction?
6. What is Romosozumab?
Presenter: Dr. Rick Adachi, BSc, MD, FRCP(C)